RAPID DISPATCH
24/H dispatch
5 in stock
YVOIRE Y-SOLUTION 720 is a cross-linked hyaluronic acid-based dermal filler developed by LG Chem for wrinkle correction, volume increase and remodelling of facial contours. Characterised by an optimal combination of elasticity and cohesiveness, this product is formulated to deliver natural, long-lasting results with a high safety profile.
The gel contains high-molecular-weight hyaluronic acid 20 mg/ml, lidocaine 0.3 % for a more comfortable treatment and a phosphate-buffered saline solution (physiological pH), ensuring smooth integration into the skin tissue.
USE MEDICAL STRICT. Medical device. Use reserved for dermatologists and aesthetic doctors because they require a medical procedure.
YVOIRE Y-SOLUTION 720 is a gel:
- It offers natural and progressive results without creating excessive volume.
- High volumising force (G’ 517 Pa) and tissue stability.
- High cohesiveness (160 gf).
- Lift Capacity 71,064.
- S-HICE TECHNOLOGY.
- LG CHEM
- NAME: YVOIRE Y-SOLUTION 720
- COMPOSITION: Cross-linked hyaluronic acid 20 mg/ml, Lidocaine 3 mg, phosphate-buffered saline solution, q.b.
- PRESENTATION: 1 x 1 ml.
- NEEDLES: 2 x 27G.
- INDICATIONS: Temporary wrinkle improvement and volume restoration by injection of cross-linked hyaluronic acid containing lidocaine into the skin layer of the adult face.
- INJECTION DEPTH: superficial dermis - medium dermis.
- DURATION: 12 to 18 months.
- USE: Strict medical use.
- Syringe: 1 x 1 ml.
- Needles: 2 x 27G.
Cheekbones, chin, jaw line and facial profile.
Cross-linked hyaluronic acid 20 mg/ml, Lidocaine 3 mg, Phosphate-buffered saline solution, q.b.
- The product must only be used by qualified medical personnel experienced in aesthetic medicine.
- Carry out a thorough patient history before treatment, assessing allergies, current therapies and clinical conditions.
- Use strict aseptic techniques and sterile disposable material.
- Avoid administration in areas recently treated with other injectable devices, unless medically assessed.
- Do not mix the product with other substances or drugs not expressly indicated.
- Take special care to avoid intravascular injections, especially in areas of high anatomical risk.
- Inform the patient of the possible occurrence of transient local reactions (redness, oedema, slight pain, ecchymosis or tightness).
- After treatment, avoid exposure to intense heat, UV radiation, vigorous massage or intense physical activity for the period indicated by the doctor.
YVOIRE Y-SOLUTION 720 is contraindicated in the following cases:
- Known hypersensitivity or allergy to hyaluronic acid or any of the components of the product.
- Presence of active skin infections, inflammation, dermatitis or lesions in the area to be treated.
- Active autoimmune diseases or uncontrolled conditions of immunodepression.
- Pregnancy and lactation.
- Previous significant adverse reactions to hyaluronic acid-based injectable treatments.
- Clotting disorders or unstabilised anticoagulant therapy.
- Patients below the age stipulated in the device indications.
Anti-ageing treatments with a need for firmness and durability.
Correction of moderate volumes.
Improved definition of facial contours.
Reduction of static and dynamic wrinkles with a natural effect.
It is a dermal filler based on hyaluronic acid cross-linked with lidocaine, designed to reshape facial contours and correct moderate wrinkles.
It is injected into the superficial or mid-dermis using sterile 27G needles by qualified medical personnel.
It improves the definition of facial contours, restores moderate volumes and reduces static and dynamic wrinkles with a natural and long-lasting effect.
Only dermatologists and aesthetic physicians experienced in injectable procedures can administer YVOIRE Y-SOLUTION 720, respecting aseptic techniques and patient safety.
Before treatment, it is important to assess allergies, current therapies, clinical conditions and areas previously treated with other fillers to reduce the risk of adverse reactions.